HYLAFEM BORICUM ACIDUM 3X
NDC 52747-255, Boricum Acidum, suppository, from U.S. PHARMACEUTICAL CORPORATION.
- Product NDC
- 52747-255
- Status
- Listed
- Labeler
- U.S. PHARMACEUTICAL CORPORATION
- Dosage form
- SUPPOSITORY
- Route
- VAGINAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/52747-255 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BORIC ACID3 [hp_X]/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 52747-255-03 | 52747025503 | 1 CAPSULE in 1 CARTON (52747-255-03) / 3 SUPPOSITORY in 1 CAPSULE |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 52747-255 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/52747-255 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 52747-255. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.